Articles by Erin Slifka

The coffee chain, long known for premium brews, is pumping out more deals to woo price-sensitive customers.

Speedy weight loss from drugs used to fight obesity and diabetes has left some users looking gaunt and aged. The boss of Swiss skincare group Galderma thinks treatments for what has been dubbed “Ozempic face” could give the company a lift.

Altria’s NJOY brand won FDA authorization for four products, after the agency previously ordered many menthol-flavored vapes off the market.

New advancements may mean that we turn more decision-making over to machines. Is that a good thing?

The sportswear brand said it has agreed to pay $434 million to settle claims related to past company financials and focus on its restructuring plan.

Dolan’s contract, which was set to expire at the end of the month, now runs through June 30, 2027.

Ex-Ontrak chairman was accused of abusing trading strategy that usually shields executives against suspicions of insider trading.

The company may receive up to $247 million in proceeds if all warrants covered by the registration statement are exercised for cash.

The owner of CBS, MTV, Nickelodeon and the Paramount film studio said that D’Alimonte’s exit will be considered a termination without cause.